{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T12:39:48Z","timestamp":1773664788085,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.ejphar.2009.02.042","type":"journal-article","created":{"date-parts":[[2009,3,10]],"date-time":"2009-03-10T04:40:21Z","timestamp":1236660021000},"page":"96-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["A randomized, controlled study on the influence of acetaminophen, diclofenac, or naproxen on aspirin-induced inhibition of platelet aggregation"],"prefix":"10.1016","volume":"609","author":[{"given":"Katja S.","family":"Galliard-Grigioni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter H.","family":"Reinhart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2009.02.042_bib1","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.thromres.2005.02.005","article-title":"Effect of increasing doses of aspirin on platelet function as measured by PFA-100 in patients with diabetes","volume":"116","author":"Abaci","year":"2005","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ejphar.2009.02.042_bib2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.ejphar.2009.02.042_bib3","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1111\/j.1365-2044.2004.03907.x","article-title":"Effect of non-selective, non-steroidal anti-inflammatory drugs and cyclo-oxygenase-2 selective inhibitors on the PFA-100 closure time","volume":"59","author":"Blaicher","year":"2004","journal-title":"Anaesthesia"},{"key":"10.1016\/j.ejphar.2009.02.042_bib4","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM200011233432103","article-title":"Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis","volume":"343","author":"Bombardier","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2009.02.042_bib5","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa050493","article-title":"Adenomatous Polyp Prevention on Vioxx (APPROVe) Trial Investigators. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial","volume":"352","author":"Bresalier","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2009.02.042_bib6","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.jacc.2005.01.045","article-title":"Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects","volume":"45","author":"Capone","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2009.02.042_bib7","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa003199","article-title":"Cyclooxygenase inhibitors and the antiplatelet effects of aspirin","volume":"345","author":"Catella-Lawson","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2009.02.042_bib8","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1161\/CIRCULATIONAHA.105.595793","article-title":"Nonsteroidal anti-inflammatory drugs, acetaminophen, and the risk of cardiovascular events","volume":"113","author":"Chan","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2009.02.042_bib9","doi-asserted-by":"crossref","first-page":"13926","DOI":"10.1073\/pnas.162468699","article-title":"COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic\/antipyretic drugs: cloning, structure, and expression","volume":"99","author":"Chandrasekharan","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2009.02.042_bib10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijcard.2004.03.069","article-title":"Prevalence of aspirin resistance measured by PFA-100","volume":"101","author":"Coma-Canella","year":"2005","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ejphar.2009.02.042_bib11","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.clinthera.2005.01.011","article-title":"Double-blind, randomized, parallel, placebo-controlled study of ibuprofen effects on thromboxane B2 concentrations in aspirin-treated healthy adult volunteers","volume":"27","author":"Cryer","year":"2005","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ejphar.2009.02.042_bib12","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMra071014","article-title":"Platelet activation and atherothrombosis","volume":"357","author":"Davi","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2009.02.042_bib13","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1136\/ard.2006.066001","article-title":"Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen, or lumiracoxib","volume":"66","author":"Farkouh","year":"2007","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ejphar.2009.02.042_bib14","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1055\/s-2005-916675","article-title":"Monitoring acetylsalicylic acid effects with the platelet function analyzer PFA-100","volume":"31","author":"Feuring","year":"2005","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.ejphar.2009.02.042_bib15","doi-asserted-by":"crossref","first-page":"11B","DOI":"10.1016\/0002-9149(91)90379-Y","article-title":"Mechanisms of platelet activation: thromboxane A2 as an amplifying signal for other agonists","volume":"68","author":"FitzGerald","year":"1991","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejphar.2009.02.042_bib16","doi-asserted-by":"crossref","first-page":"2547-2452","DOI":"10.1111\/j.1538-7836.2006.02239.x","article-title":"Platelet function in patients with acute coronary syndrome (ACS) predicts recurrent ACS","volume":"4","author":"Fuchs","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.ejphar.2009.02.042_bib17","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1096\/fasebj.5.9.1907252","article-title":"Human platelet\/erythroleukemia cell prostaglandin G\/H synthase: cDNA cloning, expression, and gene chromosomal assignment","volume":"5","author":"Funk","year":"1991","journal-title":"FASEB. J."},{"key":"10.1016\/j.ejphar.2009.02.042_bib18","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1161\/01.CIR.0000132491.96623.04","article-title":"Nonsteroidal anti-inflammatory drugs and the risk of myocardial infarction in the general population","volume":"109","author":"Garcia Rodriguez","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2009.02.042_bib19","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00415-003-0954-y","article-title":"Aspirin non-responder status in patients with recurrent cerebral ischemic attacks","volume":"250","author":"Grundmann","year":"2003","journal-title":"J. Neurol."},{"key":"10.1016\/j.ejphar.2009.02.042_bib20","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1136\/bmj.332.7553.1302","article-title":"Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomized trials","volume":"332","author":"Kearney","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.ejphar.2009.02.042_bib21","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.pain.2006.10.020","article-title":"Acetaminophen selectively suppresses peripheral prostaglandin E2 release and increases COX-2 gene expression in a clinical model of acute inflammation","volume":"129","author":"Lee","year":"2007","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2009.02.042_bib22","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/0090-6980(82)90123-X","article-title":"Indomethacin prevents the long-lasting inhibitory effect of aspirin on human platelet cyclo-oxygenase activity","volume":"23","author":"Livio","year":"1982","journal-title":"Prostaglandins"},{"key":"10.1016\/j.ejphar.2009.02.042_bib23","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nsb0895-637","article-title":"The structural basis of aspirin activitiy inferred from the crystal structure of inactivated prostaglandin H2 synthase","volume":"2","author":"Loll","year":"1995","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.ejphar.2009.02.042_bib24","doi-asserted-by":"crossref","first-page":"7330","DOI":"10.1021\/bi952776w","article-title":"Synthesis and use of iodinated nonsteroidal anti-inflammatory drug analogs as crystallographic probes of the prostaglandin H2 synthase cyclooxygenase active site","volume":"35","author":"Loll","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejphar.2009.02.042_bib25","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0140-6736(03)12509-3","article-title":"Effect of ibuprofen on cardioprotective effect of aspirin","volume":"361","author":"MacDonald","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2009.02.042_bib26","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1001\/jama.296.13.jrv60011","article-title":"Cardiovascular risk and inhibition of cyclooxygenase. A systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2","volume":"296","author":"McGettigan","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ejphar.2009.02.042_bib27","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1096\/fj.06-6615com","article-title":"Stronger, inhibition by nonsteroidal anti-inflammatory drugs of cyclooxygenase-1 in endothelial cells than platelets offers an explanation for increased risk of thrombotic events","volume":"14","author":"Mitchell","year":"2006","journal-title":"FASEB. J."},{"key":"10.1016\/j.ejphar.2009.02.042_bib28","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/bja\/ael108","article-title":"Influence on platelet aggregation of i.v. parecoxib and acetaminophen in healthy volunteers","volume":"97","author":"Munsterhjelm","year":"2006","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.ejphar.2009.02.042_bib29","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1006\/abbi.2000.2232","article-title":"Mechanism of acetaminophen inhibition of cyclooxygenase isoforms","volume":"387","author":"Ouellet","year":"2001","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejphar.2009.02.042_bib30","first-page":"661","article-title":"COX-2 is not involved in thromboxane biosynthesis by activated human platelets","volume":"50","author":"Patrignani","year":"1999","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.02.042_bib31","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/367243a0","article-title":"The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1","volume":"367","author":"Picot","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2009.02.042_bib32","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1161\/01.ATV.3.4.383","article-title":"Ibuprofen protects platelet cyclooxygenase from irreversible inhibition by aspirin","volume":"3","author":"Rao","year":"1983","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.ejphar.2009.02.042_bib33","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1016\/S0140-6736(07)61909-6","article-title":"Are COX-2-inhibitors preferable to non-selective non-steroidal anti-inflammatory drugs in patients with risk of cardiovascular events taking low-dose aspirin?","volume":"370","author":"Strand","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2009.02.042_bib34","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1177\/009127000004001005","article-title":"Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 versus COX-1 in healthy volunteers","volume":"40","author":"Van Hecken","year":"2000","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.02.042_bib35","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0002-9149(01)02265-2","article-title":"Comparison of thromboembolic events in patients treated with celecoxib, a cyclooxygenase-2 specific inhibitor, versus ibuprofen or diclofenac","volume":"89","author":"White","year":"2002","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejphar.2009.02.042_bib36","doi-asserted-by":"crossref","first-page":"443","DOI":"10.4414\/smw.2002.10039","article-title":"Evaluation of a Platelet Function Analyser (PFA-100) in patients with a bleeding tendency","volume":"132","author":"Wuillemin","year":"2002","journal-title":"Swiss Med. Wkly."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429990900199X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429990900199X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T03:59:24Z","timestamp":1762142364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429990900199X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":36,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S001429990900199X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2009.02.042","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A randomized, controlled study on the influence of acetaminophen, diclofenac, or naproxen on aspirin-induced inhibition of platelet aggregation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2009.02.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}